相关实验视频
Updated: Sep 10, 2025

12:18
An Instrumented Pull Test to Characterize Postural Responses
Published on: April 6, 2019
10.9K
与健康对照组相比,在帕金森病中推移效率及其与步骤长度的关系
Diego Tosatto1, Daniele Bonacina1, Cecilia Perin1
1School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy; Istituti Clinici Zucchi - Gruppo San Donato, Carate Brianza (MB), Italy.
Journal of biomechanics
|August 23, 2025
概括
帕金森病 (PD) 患者的步骤长度减少,这是一个常见的步行障碍. 这项研究发现,与健康对照组不同,PD患者的步骤长度与中腹肌激活之间没有相关性.
科学领域:
- 神经学
- 生物力学
- 运动障碍
背景情况:
- 减少步骤长度是帕金森病 (PD) 的标志性步行障碍.
- 导致PD这种步态变化的基础神经肌肉机制尚不清楚.
- 研究肌肉活动与步骤长度之间的关系对于了解PD步态病理至关重要.
研究的目的:
- 在患有帕金森病 (PD) 和健康对照者 (HC) 中检查步骤长度与中胃肌活化之间的关联.
- 确定PD患者和HC患者之间与步行障碍相关的神经肌肉策略的潜在差异.
主要方法:
- 使用线性回归模型进行观察研究,以评估推出阶段中腹肌和EMG活动之间的关系.
- 通过EMG外曲线下的面积 (AUC) 量化肌肉激活,并将其正常化为峰值激活.
- 在PD和HC组之间对时间变化的EMG配置文件和步骤长度进行比较分析.
主要成果:
- 与健康对照组相比,帕金森病患者的步伐长度在绝对值和正常化时均显著减少.
- 在健康对照群中观察到步骤长度与中腹肌激活之间的显著正相关性 (r=0. 623, p=0. 007).
- 在帕金森病小组中,没有发现步骤长度和胃半径激活之间的显著相关性 (r=0. 214, p=0. 294).
结论:
- 在帕金森病中观察到的步骤长度的缩短与走路推开阶段的中胃肌活动没有直接关联.
- 这种分离表明,与健康个体不同的神经肌肉机制是PD缩短步骤的基础.
- 需要进一步的研究来阐明这些导致帕金森病走路障碍的替代机制.
相关概念视频
Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377

